Vericel Stock Analysis

VCEL Stock  USD 33.50  0.50  1.47%   
The main objective of Vericel Corp stock analysis is to determine its intrinsic value, which is an estimate of what Vericel Corp Ord is worth, separate from its market price. There are two main types of Vericel Corp's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Vericel Corp's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Vericel Corp's stock to identify patterns and trends that may indicate its future price movements.
The Vericel Corp stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Vericel Corp is usually not traded on Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Veterans Day ( substitute day ), Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday. Vericel Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Vericel Corp's ongoing operational relationships across important fundamental and technical indicators.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

Vericel Stock Analysis Notes

About 99.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 357.33. Vericel Corp Ord recorded a loss per share of 0.28. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 16th of October 2013. Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Vericel operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 281 people. For more information please call Dominick Colangelo at 617 588 5555 or visit

Vericel Corp Quarterly Cost of Revenue

15.98 Million

Vericel Corp Ord Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Vericel Corp's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Vericel Corp Ord or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Vericel Corp Ord generated a negative expected return over the last 90 days
Vericel Corp Ord is unlikely to experience financial distress in the next 2 years
The company reported the previous year's revenue of 164.37 M. Net Loss for the year was (16.71 M) with profit before overhead, payroll, taxes, and interest of 109.79 M.
Vericel Corp Ord has a strong financial position based on the latest SEC filings
Over 99.0% of the company outstanding shares are owned by institutional investors
Latest headline from Vericel to Present at the Morgan Stanley Global Healthcare Conference

Vericel Corp Ord Upcoming and Recent Events

Earnings reports are used by Vericel Corp to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Vericel Corp previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of November 2023
Upcoming Quarterly Report
22nd of February 2024
Next Financial Report
30th of September 2023
Next Fiscal Quarter End
22nd of February 2024
Next Fiscal Year End
30th of June 2023
Last Quarter Report
31st of December 2022
Last Financial Announcement

Vericel Largest EPS Surprises

Earnings surprises can significantly impact Vericel Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Vericel Corp SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Vericel Corp prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Vericel Corp investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Vericel Corp Ord specific information freely available to individual and institutional investors to make a timely investment decision.
20th of September 2023
Financial Statements and Exhibits. Other Events
2nd of August 2023
Financial Statements and Exhibits. Results of Operations and Financial Condition
10th of May 2023
Financial Statements and Exhibits. Results of Operations and Financial Condition
5th of May 2023
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
23rd of February 2023
Financial Statements and Exhibits. Results of Operations and Financial Condition
14th of February 2023
Unclassified Corporate Event
9th of February 2023
Unclassified Corporate Event
24th of January 2023
Unclassified Corporate Event

Vericel Corp Thematic Classifications

In addition to having Vericel Corp stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products Idea
Pharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Vericel Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.62 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vericel Corp's market, we take the total number of its shares issued and multiply it by Vericel Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Vericel Profitablity

Vericel Corp's profitability indicators refer to fundamental financial ratios that showcase Vericel Corp's ability to generate income relative to its revenue or operating costs. If, let's say, Vericel Corp is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Vericel Corp's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Vericel Corp's profitability requires more research than a typical breakdown of Vericel Corp's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.08) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.08.
Last ReportedProjected for 2023
Return on Investment(9.41)(10.15)
Return on Average Assets(0.07)(0.07)
Return on Average Equity(0.09)(0.10)
Return on Invested Capital(0.07)(0.08)
Return on Sales(0.1)(0.10)

Management Efficiency

Vericel Corp Ord has return on total asset (ROA) of (0.0334) % which means that it has lost $0.0334 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0705) %, meaning that it created substantial loss on money invested by shareholders. Vericel Corp's management efficiency ratios could be used to measure how well Vericel Corp manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return on Investment is estimated to slide to -10.15. The value of Return on Average Assets is estimated to slide to -0.07. Vericel Corp Average Assets are quite stable at the moment as compared to the past year. The company's current value of Average Assets is estimated at 271.39 Million. Tangible Asset Value is expected to rise to about 286.5 M this year, although the value of Revenue to Assets will most likely fall to 0.55.
Last ReportedProjected for 2023
Book Value per Share 4.08  4.40 
Enterprise Value over EBIT(79.00)(81.08)
Enterprise Value over EBITDA(105.38)(108.15)
Price to Book Value 6.47  6.57 
Tangible Assets Book Value per Share 5.63  5.13 
Enterprise Value1.2 B977.5 M
Tangible Asset Value265.5 M286.5 M
The analysis of Vericel Corp's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Vericel Corp's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Vericel Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Short Long Term Debt Total
47.6 M
Interest Expense
366 K
Total Operating Expenses
126.8 M
Common Stock Total Equity
593.2 M

Technical Drivers

As of the 27th of September, Vericel Corp has the Coefficient Of Variation of (2,461), risk adjusted performance of (0.017661), and Variance of 6.0. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vericel Corp Ord, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Vericel Corp Ord, which can be compared to its competition. Please validate Vericel Corp Ord market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Vericel Corp is priced more or less accurately, providing market reflects its prevalent price of 33.5 per share. Given that Vericel Corp Ord has information ratio of (0.037886), we advise you to double-check Vericel Corp Ord's current market performance to make sure the company can sustain itself at a future point.

Vericel Corp Ord Price Movement Analysis

Execute Study
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Vericel Corp middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Vericel Corp Ord. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Vericel Corp Ord Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vericel Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vericel Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vericel Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Vericel Corp Technical and Predictive Indicators

Vericel Corp Forecast Models

Vericel Corp's time-series forecasting models are one of many Vericel Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vericel Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Vericel Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vericel Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vericel shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Vericel Corp. By using and applying Vericel Stock analysis, traders can create a robust methodology for identifying Vericel entry and exit points for their positions.
Last ReportedProjected for 2023
Operating Margin(10.38)(11.20)
EBITDA Margin(0.07)(0.08)
Gross Margin 0.67  0.70 
Profit Margin(0.10)(0.11)

Current Vericel Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vericel analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vericel analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Vericel Corp Ord current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Vericel analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Vericel stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Vericel Corp Ord, talking to its executives and customers, or listening to Vericel conference calls.
Vericel Analyst Advice Details

Vericel Stock Analysis Indicators

Vericel Corp Ord stock analysis indicators help investors evaluate how Vericel Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Vericel Corp shares will generate the highest return on investment. By understating and applying Vericel Corp stock analysis, traders can identify Vericel Corp position entry and exit signals to maximize returns.
Begin Period Cash Flow68.5 M
Common Stock Shares Outstanding47.1 M
Total Stockholder Equity192.3 M
Total Cashflows From Investing Activities-36.2 M
Tax Provision721 K
Quarterly Earnings Growth Y O Y0.343
Property Plant And Equipment Net57.4 M
Cash And Short Term Investments119.5 M
Cash51.1 M
Accounts Payable16.9 M
Net Debt-3.5 M
50 Day M A34.2374
Total Current Liabilities37.5 M
Other Operating Expenses181.4 M
Non Current Assets Total86.1 M
Forward Price Earnings370.3704
Common Stock Total Equity593.2 M
Non Currrent Assets Other1.3 M
Stock Based Compensation37.2 M
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Vericel Corp Ord information on this page should be used as a complementary analysis to other Vericel Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Vericel Stock analysis

When running Vericel Corp's price analysis, check to measure Vericel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vericel Corp is operating at the current time. Most of Vericel Corp's value examination focuses on studying past and present price action to predict the probability of Vericel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vericel Corp's price. Additionally, you may evaluate how the addition of Vericel Corp to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bond Directory
Find actively traded corporate debentures issued by US companies
Is Vericel Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.